Bulat Pharmaceutical is a finished-dose manufacturer based in India. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $291K of exports covering 5 molecules to 1 destination in 2025.
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $291K | 1 |
| 2024 | Not reported | $320K | 1 |
| 2023 | Not reported | $226K | 1 |
| 2022 | Not reported | $436K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Bulat Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free